Safety and immunogenicity of thiomersal-free recombinant hepatitis E vaccine: A randomized, double-blind, active-controlled study.

Li J, Wang X, Zhang D, Xie F, Zhong S, Yu X, Chen S, Huang Q, Wang R, Zhang Q, Zhang D.

Open source

DOI
10.1016/j.vaccine.2025.127510
Published
2025-07-20
Container
Vaccine
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2025.127510,
  title = {Safety and immunogenicity of thiomersal-free recombinant hepatitis E vaccine: A randomized, double-blind, active-controlled study.},
  author = {Li J and  Wang X and  Zhang D and  Xie F and  Zhong S and  Yu X and  Chen S and  Huang Q and  Wang R and  Zhang Q and  Zhang D.},
  year = {2025},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2025.127510},
  url = {https://doi.org/10.1016/j.vaccine.2025.127510}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of thiomersal-free recombinant hepatitis E vaccine: A randomized, double-blind, active-controlled study.
AU  - Li J
AU  -  Wang X
AU  -  Zhang D
AU  -  Xie F
AU  -  Zhong S
AU  -  Yu X
AU  -  Chen S
AU  -  Huang Q
AU  -  Wang R
AU  -  Zhang Q
AU  -  Zhang D.
PY  - 2025
JO  - Vaccine
DO  - 10.1016/j.vaccine.2025.127510
UR  - https://doi.org/10.1016/j.vaccine.2025.127510
ER  - 

APA

J, L., X, W., D, Z., F, X., S, Z., X, Y., S, C., Q, H., R, W., Q, Z., & D., Z. (2025). Safety and immunogenicity of thiomersal-free recombinant hepatitis E vaccine: A randomized, double-blind, active-controlled study.. Vaccine. https://doi.org/10.1016/j.vaccine.2025.127510

Source records